Exploring the link between maternal gut microbiome and perinatal depression and anxiety
Official title: Targeting Maternal Gut to Improve Mental Health Outcomes-- A Feasibility Pilot Clinical Trial
Run by The Canadian College of Naturopathic Medicine · NCT06074250 · Data updated 2026-11-12
This study is testing if improving gut health with diet and supplements can help pregnant women who have a history of depression and anxiety feel better during and after pregnancy.
Quick facts
| Phase | Phase2; Phase3 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 43 Years |
| Sex | Women only |
| Enrollment | 100 (estimated) |
| Sponsor | The Canadian College of Naturopathic Medicine Academic / other |
| Locations | 1 site (Toronto, Ontario) |
| Status | Recruiting |
| Started | August 15, 2024 |
| Main results expected | December 2027 |
| Study ends | March 2028 |
| Registry record updated | August 27, 2024 |
| Trial ID | NCT06074250 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are pregnant women aged 18-43 with a history of depression or anxiety who are currently stable and between 12-35 weeks of gestation.
✕Probably not a fit
Patients with a BMI of 30 or higher, major mental health disorders, or severe medical conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the relationship between the gut microbiome and perinatal depression and anxiety (PDA) in pregnant women with a history of these conditions. A total of 100 participants will be recruited and randomly assigned to one of four groups receiving dietary and supplemental interventions, including fish oil, probiotics, and prebiotics. Participants will complete six study visits over 9-12 months, during which dietary intake, mental health scores, and stool samples will be collected to assess the feasibility of the intervention. The study aims to optimize gut health as a potential management strategy for PDA.
Why it matters
Potential benefit: If successful, this study could provide a non-pharmacological approach to managing perinatal depression and anxiety, improving maternal and child health outcomes.
How similar studies have gone: Other studies have shown promising results in using dietary interventions to influence gut microbiome and mental health, suggesting potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria * Women 18-43 years old * 12-35 weeks of gestation * Non-smoker/alcohol/recreational drug user * Financially stable * Clinical diagnosis of lifetime depression/anxiety or PDA but currently well * English speaking Exclusion Criteria: * Body Mass Index (BMI)≥30 * Low income (unable to afford basic daily needs (i.e., shelter, food, etc.) * Diagnosis with other major mental health disorders (Bipolar, Psychosis, Addiction, Schizophrenia); * Diagnosis with other severe medical conditions (i.e. epilepsy, neurological disorders, etc.) * Allergies to fish oils/ingredients in supplements * Conditions that require repeated/chronic antibiotic usage * Having a child with significant mental/physical disability * Single mothers without any kind of family support, * Cigarette, alcohol and recreational drug users * Women unwilling to switch to study product(s) * Multiparous women with young children (i.e. one or more children less than 4 years of age at the time of delivery) * Non-English Readers/Speakers
Where it's running
-
Sunnybrook Health Science Center
Toronto, Ontario, Canada Recruiting
Study contacts
- Principal investigator: Neda Ebrahimi, PhD — Canadian College of Naturopathic Medicine
- Study coordinator: Neda Ebrahimi, PhD
- Email: nebrahimi@ccnm.edu
- Phone: 416-498-1255
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Two-Door Doulas: Enhanced vs Standard Medicaid Doula Care in Pregnancy
This trial tests whether an enhanced, earlier, and more frequent doula support program helps pregnant people on Medicaid feel less depression and anxiety after birth compared with the standard Medicaid doula care in Florida.
-
Personalized mobile health support to prevent maternal depression and anxiety during pregnancy
A personalized mobile health program added to ordinary care is tested to see if it can prevent depression and anxiety in pregnant people and support partners.
-
Early referral in perinatal mental health approach
We’re testing a mobile program in routine maternal care to see if early detection and referral for depression and anxiety in pregnant and recently postnatal women is feasible and acceptable, and whether an AI screening tool can help identify those at risk.
-
Parents and Babies: a virtual and hybrid program to support perinatal mood for LGBTQ+ parents
A pilot program tests a Parents and Babies intervention to see if it’s feasible, acceptable, and potentially helpful for LGBTQ+ people who are pregnant or within a year postpartum and have mild depressive symptoms.
-
Virtual forest mindfulness for pregnant women
A randomized trial tests whether a VR forest mindfulness program helps improve mental health for pregnant women around 20–24 weeks of gestation, compared with standard mindfulness training.
-
Health and Response: Digital Markers for Outcomes in Perinatal Depression Treatment
This study tests whether data from phones and wearables collected early in perinatal depression treatment can better predict outcomes when added to self-reported symptoms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.